Compile Data Set for Download or QSAR
Report error Found 178 Enz. Inhib. hit(s) with all data for entry = 3889
TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403592(US10335409, Example 2 | Preparation of (1aR,5S,8S,...)
Affinity DataKi:  0.0100nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403653(US10335409, Example 63 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0100nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403676(US10335409, Example 87 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0200nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403677(US10335409, Example 88 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0200nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403609(US10335409, Example 19 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0200nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403636(US10335409, Example 46 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403652(US10335409, Example 62 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403653(US10335409, Example 63 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403618(US10335409, Example 28 | (3aR,7S,10S,11S,12R,24aR)...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403634(US10335409, Example 44 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403666(US10335409, Example 76 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403664(US10335409, Example 74 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403617(US10335409, Example 27 | (3aR,7S10S,1S,12R,24aR)-7...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403665(US10335409, Example 75 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403678(US10335409, Example 89 | (1aR,5S,8S,9S,10R,19E,22a...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403628(US10335409, Example 38 | (1aR,5S,8S,9S,10R,22aR)&#...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403661(US10335409, Example 71 | (4aR,8S,11S,12S,13R,25aR)...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403674(US10335409, Example 85 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403643(US10335409, Example 53 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403608(US10335409, Example 18 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403591(US10335409, Example 1 | Preparation of (1aR,5S,8S,...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403623(US10335409, Example 33 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403671(US10335409, Example 82 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0300nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403652(US10335409, Example 62 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403650(US10335409, Example 60 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403603(US10335409, Example 13 | (1R,4S,4aR,8S,11S,12S,13R...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403635(US10335409, Example 45 | (1aS,5S,8S,9S,10R,22aS)-5...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403649(US10335409, Example 59 | (1aS,2aR,6S,9S,10 S,11R,2...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403595(US10335409, Example 5 | Preparation of (3aR,7S,10S...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403675(US10335409, Example 86 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403671(US10335409, Example 82 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403656(US10335409, Example 66 | (4aR,8S,11 S,12S,13R,25aR...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403592(US10335409, Example 2 | Preparation of (1aR,5S,8S,...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403657(US10335409, Example 67 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403673(US10335409, Example 84 | (1aR,5S,8S,9S,10R,19E,22a...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403670(US10335409, Example 81 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403607(US10335409, Example 17 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403639(US10335409, Example 49 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0400nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403636(US10335409, Example 46 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403605(US10335409, Example 15 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403616(US10335409, Example 26 | (1R,4S,4aR,8S,11S,12S,13R...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403614(US10335409, Example 24 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403662(US10335409, Example 72 | (4aS,8S,11S,12S,13R,25aS)...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403678(US10335409, Example 89 | (1aR,5S,8S,9S,10R,19E,22a...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403615(US10335409, Example 25 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403660(US10335409, Example 70 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403660(US10335409, Example 70 | (1aS,2aR,6S,9S,10S,11R,23...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403676(US10335409, Example 87 | (1aR,5S,8S,9S,10R,22aR)-5...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403597(US10335409, Example 7 | Preparation of (1aR,5S,8S,...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

TargetGenome polyprotein(HCV)
Gilead Pharmasset

US Patent
LigandPNGBDBM403658(US10335409, Example 68 | (4aR,8S,11 S,12S,13R,25aS...)
Affinity DataKi:  0.0500nMAssay Description:Purified NS3 protease domain (amino acids 1-181) of the genotype 1b and 3a virus were generated as above. The internally quenched fluorogenic depsipe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/31/2020
Entry Details
US Patent

Displayed 1 to 50 (of 178 total ) | Next | Last >>
Jump to: